# Dutogliptin in Co-administration With Filgrastim in Early Recovery Post-myocardial Infarction

> **NCT05881382** · PHASE3 · UNKNOWN · sponsor: **Recardio, Inc.** · enrollment: 4100 (estimated)

## Conditions studied

- ST Elevation Myocardial Infarction

## Interventions

- **DRUG:** Dutogliptin + Filgrastim
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05881382
- **Lead sponsor:** Recardio, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-09
- **Primary completion:** 2025-09
- **Final completion:** 2025-09
- **Target enrollment:** 4100 (ESTIMATED)
- **Last updated:** 2023-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05881382

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05881382, "Dutogliptin in Co-administration With Filgrastim in Early Recovery Post-myocardial Infarction". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05881382. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*